|Articles|March 18, 2022
Supplying CleanCap® Reagent for a COVID-19 Vaccine
Author(s)TriLink BioTechnologies
This case study demonstrates scale-up of mRNA supply chain, increased quality standards, and global supply capabilities within record-breaking time.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
